Our Pipeline

Project
Indication
Target
Modality
Route
Discovery
Pre-clinical
Clinical Trial
Parters

SD-B03

Obesity

GLP-1R

Peptide

TD

 
 

SD-B05 *

Focal hyperhidrosis
&Seborrhea

BoNT

Protein

TD

 
 
 

SD-C01 *

CRSwNP

IL-4Rα

Antibody

IN

 

SD-I01

Rare lung
disease

Undisclosed

Small
molecules

IH
(Inhaled)

 

*  NOTE : The technology is exclusively owned by Sinedore Bioscience Inc., a subsidiary of Sinedore Holdings, and is not licensed to any other subsidiaries.

SL - Sublingual; TD - Transdermal; IN - Intranasal

CRSwNP - Chronic Rhinosinusitis with Nasal Polyps

BoNT - Botulinum toxin

Pediatric Formulation

Project
Target
Route
Discovery
POC
Partner

SD-D01

Small molecule drug

Oral

 
 

Cookie POLICY

We use cookies and similar technologies to personalize content, serve and measure ads, and enhance your experience. Click “Accept” to consent to all cookies, or click “Reject” to decline non‑essential cookies. For details, see our Privacy Policy.